Cargando…

Clinical Impact of Beta Blockers in Patients with Myocardial Infarction from the Korean National Health Insurance Database

BACKGROUND AND OBJECTIVES: Whether beta blockers favorably impact the clinical outcome in patients with acute myocardial infarction (AMI) remains in debate. We investigated the impact of beta blocker on major clinical outcomes during 2 years after percutaneous coronary intervention (PCI) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Won, Hoyoun, Suh, Yongsung, Kim, Gwang Sil, Ko, Young-Guk, Hong, Myeong-Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234850/ https://www.ncbi.nlm.nih.gov/pubmed/32096355 http://dx.doi.org/10.4070/kcj.2019.0231

Ejemplares similares

Impact of Angiotensin II Receptor Blockers on Clinical Outcomes after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction Based on Data from the Korean National Health Insurance Database (2005–2014)
por: Kim, Gwang Sil, et al.
Publicado: (2020)

Class effect of beta-blockers in survivors of ST-elevation myocardial infarction: A nationwide cohort study using an insurance claims database
por: Lin, Ting-Tse, et al.
Publicado: (2015)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Sex Differences in the Treatment and Outcome of Korean Patients With Acute Myocardial Infarction Using the Korean National Health Insurance Claims Database
por: Hong, Jae-Seok, et al.
Publicado: (2015)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Validation of Acute Myocardial Infarction Cases in the National Health Insurance Research Database in Taiwan
por: Cheng, Ching-Lan, et al.
Publicado: (2014)

Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
por: Giannakopoulos, Georgios, et al.
Publicado: (2021)

Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
por: Joo, Seung-Jae
Publicado: (2023)

Major Congenital Anomalies in Korean Livebirths in 2013–2014: Based on the National Health Insurance Database
por: Lee, Jin A, et al.
Publicado: (2023)

Validity of the Diagnosis of Acute Myocardial Infarction in Korean National Medical Health Insurance Claims Data: The Korean Heart Study (1)
por: Kimm, Heejin, et al.
Publicado: (2012)

Recurrence and Mortality Risks in Patients with First Incident Acute Stroke or Myocardial Infarction: A Longitudinal Study Using the Korean National Health Insurance Service Database
por: Park, Dougho, et al.
Publicado: (2023)

Beta-Blockers for the Secondary Prevention of Myocardial Infarction in People with Dementia: A Systematic Review
por: Lanham, David, et al.
Publicado: (2019)

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction
por: Ferreira, João André, et al.
Publicado: (2021)

Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
por: Amino, Mari, et al.
Publicado: (2021)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Beta-Blocker and Renin–Angiotensin System Inhibitor Combination Therapy in Patients with Acute Myocardial Infarction and Prediabetes or Diabetes Who Underwent Successful Implantation of Newer-Generation Drug-Eluting Stents: A Retrospective Observational Registry Study
por: Kim, Yong Hoon, et al.
Publicado: (2020)

The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data
por: Kim, Choongki, et al.
Publicado: (2017)

Operational Definitions of Colorectal Cancer in the Korean National Health Insurance Database
por: Park, Hyeree, et al.
Publicado: (2023)

Data Configuration and Publication Trends for the Korean National Health Insurance and Health Insurance Review & Assessment Database
por: Kim, Hae Kyung, et al.
Publicado: (2020)

The Potential Anti-remodeling Effect of Paroxetine After Myocardial Infarction May Be Blunted by Beta-Blockers
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
por: Hu, Mengjin, et al.
Publicado: (2022)

Cardiovascular Risks in Korean Patients with Gout: Analysis Using a National Health Insurance Service Database
por: Moon, Ki Won, et al.
Publicado: (2022)

Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean National Health Insurance Database
por: Park, Bora, et al.
Publicado: (2022)

Atrioventricular block after reperfusion: A reflection on early beta-blocker therapy for acute myocardial infarction
por: Zhong, Yue, et al.
Publicado: (2017)

Beta-blockers and renin-angiotensin system inhibitors in acute myocardial infarction managed with inhospital coronary revascularization
por: Sim, Hui Wen, et al.
Publicado: (2020)

One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction
por: Goldberger, Jeffrey J., et al.
Publicado: (2021)

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
por: Desta, Liyew, et al.
Publicado: (2020)

Data resource profile: the allergic disease database of the Korean National Health Insurance Service
por: Yoo, Sunyong, et al.
Publicado: (2021)

Rehabilitation in critically ill children: Findings from the Korean National Health Insurance database
por: Cho, Joongbum, et al.
Publicado: (2022)

Predictors of Recovery of Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: From the Korean Acute Myocardial Infarction Registry and Korean Myocardial Infarction Registry
por: Oh, Pyung Chun, et al.
Publicado: (2013)

Admission route and use of invasive procedures during hospitalization for acute myocardial infarction: analysis of 2007-2011 National Health Insurance database
por: Yeom, Hyungseon, et al.
Publicado: (2015)

Sustainability of Korean National Health Insurance
por: Kang, Myoung Sheen, et al.
Publicado: (2012)

Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
por: Kezerashvili, Anna, et al.
Publicado: (2012)

Self‐Controlled Case‐Series Study to Verify the Effect of Adherence to Beta‐Blockers in Secondary Prevention of Myocardial Infarction
por: Di Bartolomeo, Stefano, et al.
Publicado: (2015)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022)

Preterm birth and maternal heart disease: A machine learning analysis using the Korean national health insurance database
por: Lee, Jue Seong, et al.
Publicado: (2023)

Comorbidities of nontuberculous mycobacteria infection in Korean adults: results from the National Health Insurance Service–National Sample Cohort (NHIS–NSC) database
por: Lee, Seung Won, et al.
Publicado: (2022)

Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents
por: Kim, Yong Hoon, et al.
Publicado: (2023)

The effect of beta blocker withdrawal on adenosine myocardial perfusion imaging
por: Hoffmeister, C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n3ra5gtnq864omhfbs9qvu0ur0